Joachim Koerner, director e-Device, R&D Prescription Division, Aptar Pharma, discusses intranasal drug delivery and how an integrated electronic lockout device can assist with patient adherence and help prevent drug misuse.
Intranasal drug delivery has been a popular option for many therapeutics over the years. Not only does it offer an easy route of administration, it is also convenient for patients, meaning adherence is usually less of a concern.